[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Veterinary / Animal Vaccines Market by Product (Livestock, Companion, Poultry, Equine, Porcine), Diseases (Rabies, Distemper, Foot & Mouth, Gumboro, Swine& Avian Influenza, Strangles) & Technology (Live attenuated, DNA, Inactivated) - Global Forecast to 2020

June 2015 | 186 pages | ID: V770DE4BDECEN
MarketsandMarkets

US$ 5,650.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
The report segments the veterinary vaccines market on the basis of products, diseases, technologies, and regions. On basis of products, the veterinary vaccines market is categorized into companion animal vaccines, livestock vaccine, poultry vaccines, porcine vaccines, equine vaccines, aquaculture vaccines, and other animal vaccines. Among these, the companion animal vaccines segment is the fastest-growing segment due to increasing prevalence of zoonotic diseases in humans and growing pet population.

The major animal vaccine production technologies include live attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, recombinant vaccines, and DNA vaccines. The DNA vaccines segment is expected to witness highest growth in the forecast period.

New product launches and strategic collaborations were key strategies adopted by major industry players to increase their market share and cater to unmet needs. Emerging and immature markets such as the Middle East, Brazil, Argentina, Mexico, Turkey, China, and India are lucrative markets for veterinary vaccines, owing to favorable government initiatives.

From an insight perspective, this research report focuses on qualitative data, market size, and growth of various segments and subsegments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and threats). The report also offers market sizes and data on the growth of various segments in the industry. It focuses on emerging and high-growth segments, high-growth regions, and initiatives of governments. The competitive landscape covers growth strategies adopted by industry players in the last three years. The company profiles comprise basic views on key players in the veterinary vaccines market and the product portfolios, developments, and strategies adopted to maintain and increase their market shares. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms, garner a greater market share. Firms purchasing the report can use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:
  • Market Penetration: Comprehensive information on product portfolios of the top players in the veterinary vaccines market. The report analyzes the veterinary vaccines market by product and geography
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the veterinary vaccines market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the veterinary vaccines market
  • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various product across geographies
  • Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the veterinary vaccines market
1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
  1.3.1 MARKETS COVERED
  1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

2.1 MARKET SIZE ESTIMATION
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION
  2.2.1 KEY DATA FROM SECONDARY SOURCES
  2.2.2 KEY DATA FROM PRIMARY SOURCES
    2.2.2.1 Key industry insights
  2.2.3 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 VETERINARY VACCINES MARKET TO GROW AT A STEADY RATE
4.2 VETERINARY VACCINES MARKET, BY PRODUCT
4.3 VETERINARY VACCINES MARKET, BY REGION
4.4 VETERINARY VACCINES MARKET, BY TECHNOLOGY
4.5 LIFECYCLE ANALYSIS, BY REGION

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET SEGMENTATION
5.3 MARKET DYNAMICS
  5.3.1 DRIVERS
    5.3.1.1 Increase in livestock and instances of disease
    5.3.1.2 Increasing incidence of zoonotic diseases
    5.3.1.3 Increasing investments by various government agencies, animal associations, and leading players
    5.3.1.4 Introduction of new types of vaccines
  5.3.2 RESTRAINTS
    5.3.2.1 Rising maintenance costs for storage of vaccines
    5.3.2.2 Increasing prices of meat promoting the rise in adoption of vegetarian diets
  5.3.3 OPPORTUNITIES
    5.3.3.1 Technological innovations such as DNA vaccines
    5.3.3.2 Growing awareness of animal health in emerging economies

6 VETERINARY VACCINES MARKET, BY PRODUCT

6.1 INTRODUCTION

7 VETERINARY VACCINES MARKET, BY DISEASE

7.1 INTRODUCTION
7.2 PORCINE VACCINES
  7.2.1 SNAPSHOT: MARKET SHARE, BY DISEASE
7.3 POULTRY VACCINES
  7.3.1 SNAPSHOT: MARKET SHARE, BY DISEASE
7.4 COMPANION ANIMAL VACCINES
7.5 CANINE VACCINES
  7.5.1 SNAPSHOT: MARKET SHARE, BY DISEASE
7.6 FELINE VACCINES
  7.6.1 SNAPSHOT: MARKET SHARE, BY DISEASE
7.7 LIVESTOCK VACCINES
  7.7.1 BOVINE VACCINES
    7.7.1.1 Snapshot: Market Share, by Disease
  7.7.2 SMALL RUMINANT VACCINES
    7.7.2.1 Snapshot: Market Share, by Disease
7.8 EQUINE VACCINES
  7.8.1 SNAPSHOT: MARKET SHARE, BY DISEASE
7.9 AQUACULTURE VACCINES
  7.9.1 SNAPSHOT: MARKET SHARE, BY DISEASE

8 VETERINARY VACCINES MARKET, BY TECHNOLOGY

8.1 INTRODUCTION
8.2 LIVE ATTENUATED VACCINES (LAV)
8.3 INACTIVATED VACCINES
8.4 TOXOID VACCINES
8.5 RECOMBINANT VACCINES
8.6 CONJUGATE VACCINES
8.7 SUBUNIT VACCINES
8.8 DNA VACCINES

9 VETERINARY VACCINES MARKET, BY REGION

9.1 INTRODUCTION
9.2 EUROPE
9.3 NORTH AMERICA
9.4 ASIA
  9.4.1 CHINA
  9.4.2 THAILAND
    9.4.2.1 Regulatory landscape for veterinary vaccines in Thailand
  9.4.3 INDIA
9.5 REST OF THE WORLD (ROW)
  9.5.1 BRAZIL

10 COMPETITIVE LANDSCAPE

10.1 OVERVIEW
10.2 MARKET SHARE ANALYSIS
10.3 VETERINARY VACCINES MARKET, MAJOR DEVELOPMENTS, BY PRODUCT (2013–2015)
  10.3.1 RECENT DEVELOPMENTS BY MARKET PLAYERS (2013–2015)
    10.3.1.1 Zoetis (Pfizer)
    10.3.1.2 Merck Animal Health
    10.3.1.3 Boehringer Ingelheim
    10.3.1.4 Ceva Animal Health
10.4 COMPETITIVE SITUATION AND TRENDS
  10.4.1 NEW PRODUCT LAUNCHES
  10.4.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
  10.4.3 ACQUISITIONS
  10.4.4 EXPANSION
  10.4.5 OTHER DEVELOPMENTS

11 COMPANY PROFILES

(Overview, Financials, Products & Services, Strategy, & Developments)*

11.1 INTRODUCTION
11.2 BAYER HEALTHCARE
11.3 BIONICHE ANIMAL HEALTH
11.4 BOEHRINGER INGELHEIM
11.5 CEVA ANIMAL HEALTH
11.6 ELANCO ANIMAL HEALTH (ELI LILLY)
11.7 HESKA CORPORATION
11.8 MERCK ANIMAL HEALTHCARE
11.9 MERIAL INC. (SANOFI)
11.10 VIRBAC
11.11 ZOETIS

*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.

12 APPENDIX

12.1 INSIGHTS OF INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 OTHER COMPANY DEVELOPMENTS (2013–2014)
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
12.5 AVAILABLE CUSTOMIZATIONS
12.6 RELATED REPORTS

LIST OF TABLES

Table 1 GROWING INCIDENCE OF ZOONOTIC DISEASES TO DRIVE THE VETERINARY VACCINES MARKET
Table 2 HIGH MAINTENANCE AND STORAGE COST OF VACCINES TO RESTRAIN MARKET GROWTH
Table 3 TECHNOLOGICAL ADVANCEMENTS LIKELY TO BOOST THE VETERINARY VACCINES MARKET
Table 4 VETERINARY VACCINES MARKET SIZE, BY PRODUCT, 2013–2020 ($MILLION)
Table 5 PORCINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 6 POULTRY VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 7 CANINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 8 FELINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 9 BOVINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 10 SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 11 EQUINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 12 AQUACULTURE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 13 VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 14 LIVE ATTENUATED VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 15 INACTIVATED VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 16 TOXOID VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 17 RECOMBINANT VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 18 CONJUGATE VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 19 SUBUNIT VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 20 DNA VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 21 VETERINARY VACCINES MARKET SIZE, BY REGION, 2013–2020 ($MILLION)
Table 22 EUROPE: VETERINARY VACCINES MARKET SIZE, BY PRODUCT, 2013–2020 ($MILLION)
Table 23 EUROPE: PORCINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 24 EUROPE: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 25 EUROPE: LIVESTOCK VACCINES MARKET SIZE, BY CATEGORY, 2013–2020 ($MILLION)
Table 26 EUROPE: BOVINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 27 EUROPE: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 28 EUROPE: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 29 EUROPE: POULTRY VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 30 EUROPE: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 31 EUROPE: COMPANION ANIMAL VACCINES MARKET SIZE, BY CATEGORY, 2013–2020 ($MILLION)
Table 32 EUROPE: CANINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 33 EUROPE: FELINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 34 EUROPE: COMPANION ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 35 EUROPE: EQUINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 36 EUROPE: EQUINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 37 EUROPE: AQUACULTURE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 38 EUROPE: AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 39 NORTH AMERICA: VETERINARY VACCINES MARKET SIZE, BY PRODUCT, 2013–2020 ($MILLION)
Table 40 NORTH AMERICA: PORCINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 41 NORTH AMERICA: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 42 NORTH AMERICA: LIVESTOCK VACCINES MARKET SIZE, BY CATEGORY, 2013–2020 ($MILLION)
Table 43 NORTH AMERICA: BOVINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 44 NORTH AMERICA: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 45 NORTH AMERICA: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 46 NORTH AMERICA: POULTRY VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 47 NORTH AMERICA: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 48 NORTH AMERICA: COMPANION ANIMAL VACCINES MARKET SIZE, BY CATEGORY, 2013–2020 ($MILLION)
Table 49 NORTH AMERICA: CANINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 50 NORTH AMERICA: FELINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 51 NORTH AMERICA: COMPANION ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 52 NORTH AMERICA: EQUINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 53 NORTH AMERICA: EQUINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 54 NORTH AMERICA: AQUACULTURE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 55 NORTH AMERICA: AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 56 CHINA: VETERINARY VACCINES MARKET SIZE, BY PRODUCT, 2013–2020 ($MILLION)
Table 57 CHINA: PORCINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 58 CHINA: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 59 CHINA: LIVESTOCK VACCINES MARKET SIZE, BY CATEGORY, 2013–2020 ($MILLION)
Table 60 CHINA: BOVINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 61 CHINA: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 62 CHINA: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 63 CHINA: POULTRY VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 64 CHINA: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 65 CHINA: COMPANION ANIMAL VACCINES MARKET SIZE, BY CATEGORY, 2013–2020 ($MILLION)
Table 66 CHINA: CANINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 67 CHINA: FELINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 68 CHINA: COMPANION ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 69 CHINA: EQUINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 70 CHINA: EQUINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 71 CHINA: AQUACULTURE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 72 CHINA: AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 73 THAILAND: VETERINARY VACCINES MARKET SIZE, BY PRODUCT, 2013–2020 ($MILLION)
Table 74 THAILAND: PORCINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 75 THAILAND: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 76 THAILAND: POULTRY VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 77 THAILAND: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 78 THAILAND: COMPANION ANIMAL VACCINES MARKET SIZE, BY CATEGORY, 2013–2020 ($MILLION)
Table 79 THAILAND: CANINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 80 THAILAND: FELINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 81 THAILAND: COMPANION ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 82 THAILAND: LIVESTOCK ANIMAL VACCINES MARKET SIZE, BY CATEGORY, 2013–2020 ($MILLION)
Table 83 THAILAND: BOVINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 84 THAILAND: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 85 THAILAND: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 86 INDIA: VETERINARY VACCINES MARKET SIZE, BY PRODUCT, 2013–2020 ($MILLION)
Table 87 INDIA: PORCINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 88 INDIA: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 89 INDIA: LIVESTOCK VACCINES MARKET SIZE, BY CATEGORY, 2013–2020 ($MILLION)
Table 90 INDIA: BOVINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 91 INDIA: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 92 INDIA: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 93 INDIA: POULTRY VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 94 INDIA: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 95 INDIA: COMPANION ANIMAL VACCINES MARKET SIZE, BY CATEGORY, 2013–2020 ($MILLION)
Table 96 INDIA: CANINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 97 INDIA: FELINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 98 INDIA: COMPANION ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 99 INDIA: EQUINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 100 INDIA: EQUINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 101 INDIA: AQUACULTURE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 102 INDIA: AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 103 BRAZIL: VETERINARY VACCINES MARKET SIZE, BY PRODUCT, 2013–2020 ($MILLION)
Table 104 BRAZIL: PORCINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 105 BRAZIL: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 106 BRAZIL: LIVESTOCK VACCINES MARKET SIZE, BY CATEGORY, 2013–2020 ($MILLION)
Table 107 BRAZIL: BOVINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 108 BRAZIL: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 109 BRAZIL: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 110 BRAZIL: POULTRY VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 111 BRAZIL: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 112 BRAZIL: COMPANION ANIMAL VACCINES MARKET SIZE, BY CATEGORY, 2013–2020 ($MILLION)
Table 113 BRAZIL: CANINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 114 BRAZIL: FELINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 115 BRAZIL: COMPANION ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 116 BRAZIL: EQUINE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 117 BRAZIL: EQUINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 118 BRAZIL: AQUACULTURE VACCINES MARKET SIZE, BY DISEASE, 2013–2020 ($MILLION)
Table 119 BRAZIL: AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY, 2013–2020 ($MILLION)
Table 120 NEW PRODUCT LAUNCHES, 2013–2015
Table 121 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2013–2015
Table 122 ACQUISITIONS, 2013-2015
Table 123 EXPANSIONS, 2013-2015
Table 124 OTHER DEVELOPMENTS, 2012–2015

LIST OF FIGURES

Figure 1 RESEARCH DESIGN: VETERINARY VACCINES MARKET
Figure 2 MARKET SIZE ESTIMATION APPROCH
Figure 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
Figure 4 DATA TRIANGULATION METHODOLOGY
Figure 5 VETERINARY VACCINES MARKET SNAPSHOT (2015 VS. 2020): COMPANION ANIMAL VACCINES SEGMENT TO GROW AT THE HIGHEST CAGR
Figure 6 LIVE ATTENUATED VACCINES SEGMENT IS EXPECTED TO DOMINATE THE VETERINARY VACCINES TECHNOLOGIES MARKET IN 2015
Figure 7 PORCINE CIRCOVIRUS SEGMENT IS EXPECTED TO GROW AT THE HIGHEST CAGR IN THE PORCINE VACCINES MARKET
Figure 8 CANINE RABIES VACCINES SEGMENT WILL CONTINUE TO DOMINATE THE CANINE VACCINES MARKET
Figure 9 ASIA-PACIFIC MARKET TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
Figure 10 ATTRACTIVE MARKET OPPORTUNITIES
Figure 11 PORCINE VACCINES SEGMENT ACCOUNTED FOR THE LARGEST SHARE IN 2014
Figure 12 ASIA IS EXPECTED TO BE THE FASTEST-GROWING REGION DURING THE FORECAST PERIOD
Figure 13 LIVE ATTENUATED VACCINES TECHNOLOGY SEGMENT IS EXPECTED TO DOMINATE THE VETERINARY VACCINES MARKET DURING THE FORECAST PERIOD
Figure 14 ASIAN MARKET SHOWCASES LUCRATIVE GROWTH OPPORTUNITIES DURING THE FORECAST PERIOD
Figure 15 INCREASING INCIDENCE OF ZOONOTIC DISEASES TO BOOST MARKET GROWTH
Figure 16 PORCINE VACCINES COMMANDED LARGEST SHARE OF THE VETERINARY VACCINES MARKET IN 2014
Figure 17 PORCINE CIRCOVIRUS SEGMENT PROJECTED TO GROW AT HIGHEST RATE IN PORCINE VACCINES MARKET, BY 2020
Figure 18 INFECTIOUS BRONCHITIS SEGMENT DOMINATED THE POULTRY VACCINES MARKET IN 2014
Figure 19 CANINE DISTEMPER SEGMENT PROJECTED TO GROW AT HIGHEST RATE IN CANINE VACCINES MARKET BY 2020
Figure 20 FELINE RABIES SEGMENT DOMINATED FELINE VACCINES MARKET IN 2014
Figure 21 BVD SEGMENT PROJECTED TO GROW AT HIGHEST RATE IN BOVINE VACCINES MARKET BY 2020
Figure 22 CLOSTRIDIAL DISEASES SEGMENT DOMINATED THE SMALL RUMINANT VACCINES MARKET IN 2014
Figure 23 EQUINE RHINOPNEUMONITIS SEGMENT PROJECTED TO GROW AT HIGHEST RATE IN EQUINE VACCINES MARKET BY 2020
Figure 24 VIBRIOSIS SEGMENT DOMINATED THE AQUACULTURE VACCINES MARKET IN 2014
Figure 25 LIVE ATTENUATED VACCINES DOMINATED THE GLOBAL VETERINARY VACCINES MARKET IN 2014
Figure 26 POULTRY VACCINES DOMINATED THE LIVE ATTENUATED VACCINES MARKET IN 2014
Figure 27 COMPANION ANIMAL VACCINES TO WITNESS THE HIGHEST GROWTH RATE IN THE INACTIVATED VACCINES MARKET BY 2020
Figure 28 LIVESTOCK VACCINES DOMINATED THE TOXOID VACCINES MARKET IN 2014
Figure 29 PORCINE VACCINES TO GROW AT THE HIGHEST RATE IN THE RECOMBINANT VACCINES MARKET BY 2020
Figure 30 PORCINE VACCINES DOMINATED THE CONJUGATE VACCINES MARKET IN 2014
Figure 31 LIVESTOCK VACCINES TO GROW AT THE HIGHEST RATE IN THE SUBUNIT VACCINES MARKET BY 2020
Figure 32 PORCINE VACCINES DOMINATED THE DNA VACCINES MARKET IN 2014
Figure 33 GEOGRAPHIC SNAPSHOT ASIA TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD
Figure 34 ASIA, AN ATTRACTIVE DESTINATION FOR ALL PRODUCT CATEGORIES
Figure 35 EUROPE WILL CONTINUE TO LEAD THE GLOBAL VETERINARY VACCINES MARKET IN THE FORECAST PERIOD
Figure 36 THE DEMAND FOR VETERINARY VACCINES WILL BE DRIVEN BY THE GROWING PRODUCTION OF PIG MEAT IN THE FORECAST PERIOD
Figure 37 THE PORCINE VACCINES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE EUROPEAN VETERINARY VACCINES MARKET, BY PRODUCT
Figure 38 RECOMBINANT VACCINES TECHNOLOGY WILL BE THE FASTEST-GROWING SEGMENT IN EUROPEAN VETERINARY VACCINESMARKET IN THE FORECAST PERIOD
Figure 39 THE INACTIVATED VACCINES TECHNOLOGY SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE EUROPEAN COMPANION ANIMAL VACCINES MARKET
Figure 40 COMPANION ANIMAL VACCINES WILL BE THE FASTEST-GROWING SEGMENT FOR NORTH AMERICAN VETERINARY VACCINES MARKET IN THE FORECAST PERIOD
Figure 41 THE LIVE ATTENUATED VACCINES TECHNOLOGY SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICA LIVESTOCK VACCINES MARKET
Figure 42 ASIA MARKET SNAPSHOT: THE DEMAND FOR VETERINARY VACCINES WILL BE DRIVEN BY INCREASING INCIDENCES OF ZOONOTIC DISEASES
Figure 43 THE LIVESTOCK VACCINES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE VETERINARY VACCINES MARKET IN CHINA
Figure 44 CONJUGATE VACCINES TECHNOLOGY WILL BE THE FASTEST-GROWING SEGMENT FOR ASIAN VETERINARY VACCINES MARKET IN THE FORECAST PERIOD
Figure 45 THE PORCINE VACCINES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE THAILAND VETERINARY VACCINES MARKET
Figure 46 RECOMBINANT VACCINE TECHNOLOGY SEGMENT TO WITNESS THE HIGHEST GROWTH THAILAND VETERINARY VACCINES MARKET IN THE FORECAST PERIOD
Figure 47 THE LIVESTOCK VACCINES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE VETERINARY VACCINES MARKET IN INDIA
Figure 48 CONJUGATE VACCINES TECHNOLOGY SEGMENT TO WITNESS THE HIGHEST GROWTH IN LIVESTOCK VACCINES MARKET THE FORECAST PERIOD
Figure 49 THE POULTRY VACCINES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE VETERINARY VACCINES MARKET IN BRAZIL
Figure 50 INACTIVATED VACCINES TECHNOLOGY SEGMENT TO GROW AT THE HIGHEST CAGR IN POULTRY VACCINES MARKET IN THE FORECAST PERIOD
Figure 51 COMPANIES ADOPTED NEW PRODUCT LAUNCHES AND LICENSES AS THEIR KEY GROWTH STRATEGY (2013-2015)
Figure 52 GLOBAL VETERINARY VACCINES MARKET SHARE, BY KEY PLAYER, 2014
Figure 53 VETERINARY VACCINES MARKET, MAJOR DEVELOPMENTS (2013–2015)
Figure 54 ZOETIS (PFIZER) FOCUSED ON PORCINE SEGMENT IN LAST FEW YEARS (2013-2015)
Figure 55 MERCK CONCENTRATED ON LIVESTOCK SEGMENT (2013-2015)
Figure 56 BOEHRINGER INGELHEIM MAINLY CONCENTRATED ON EQUINE SEGMENT (2013-2015)
Figure 57 CEVA RELEASED NEW PRODUCTS FOR THE POULTRY SEGMENT (2013 – 2015)
Figure 58 BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES WAS THE KEY GROWTH STRATEGY
Figure 59 GEOGRAPHIC REVENUE MIX OF TOP FIVE MARKET PLAYERS
Figure 60 BAYER HEALTHCARE: COMPANY SNAPSHOT
Figure 61 BIONICHE ANIMAL HEALTH: COMPANY SNAPSHOT
Figure 62 BOEHRINGER INGELHEIM: COMPANY SNAPSHOT
Figure 63 CEVA ANIMAL HEALTH: COMPANY SNAPSHOT
Figure 64 ELANCO ANIMAL HEALTH: COMPANY SNAPSHOT
Figure 65 HESKA CORPORATION: COMPANY SNAPSHOT
Figure 66 MERCK ANIMAL HEALTHCARE: COMPANY SNAPSHOT
Figure 67 MERIAL INC. (SANOFI): COMPANY SNAPSHOT
Figure 68 VIRBAC: COMPANY SNAPSHOT
Figure 69 ZOETIS: COMPANY SNAPSHOT


More Publications